S. Saitoh

发表

Small hepatocellular carcinoma: evaluation of portal blood flow with CT during arterial portography performed with balloon occlusion of the hepatic artery.

K. Chayama, A. Tsubota, K. Ikeda, 1994, Radiology.

Diagnosis of hepatocellular carcinoma by concanavalin a affinity electrophoresis of serum alpha‐fetoprotein

K. Chayama, Yoshiyuki Suzuki, A. Tsubota, 1995, Cancer.

Biochemical and histological features of hepatitis G virus infection

K. Chayama, Yoshiyuki Suzuki, A. Tsubota, 1998, Journal of gastroenterology and hepatology.

Time course of histological changes in patients with a sustained biochemical and virological response to interferon-alpha therapy for chronic hepatitis C virus infection.

K. Chayama, A. Tsubota, Y. Suzuki, 1997, Journal of hepatology.

Molecular analysis of intraspousal transmission of hepatitis C virus.

K. Chayama, A. Tsubota, K. Ikeda, 1995, Journal of hepatology.

Randomized controlled clinical trial of lymphoblastoid interferon-alpha for chronic hepatitis C.

K. Chayama, A. Tsubota, Y. Suzuki, 2001, Hepatology research : the official journal of the Japan Society of Hepatology.

A Prospective Randomized Evaluation of a Compound of Tegafur and Uracil as an Adjuvant Chemotherapy for Hepatocellular Carcinoma Treated with Transcatheter Arterial Chemoembolization

K. Chayama, A. Tsubota, K. Ikeda, 1995, American journal of clinical oncology.

Occult hepatitis B virus infection increases hepatocellular carcinogenesis by eight times in patients with non‐B, non‐C liver cirrhosis: a cohort study

Yoshiyuki Suzuki, Y. Suzuki, K. Ikeda, 2009, Journal of viral hepatitis.

Combined ursodeoxycholic acid and glycyrrhizin therapy for chronic hepatitis C virus infection: a randomized controlled trial in 170 patients.

K. Chayama, Yoshiyuki Suzuki, A. Tsubota, 1999, European journal of gastroenterology & hepatology.

Factors predictive of response to interferon-alpha therapy in hepatitis C virus infection.

K. Chayama, A. Tsubota, K. Ikeda, 1994, Hepatology.

Genotype, slow decrease in virus titer during interferon treatment and high degree of sequence variability of hypervariable region are indicative of poor response to interferon treatment in patients with chronic hepatitis type C.

K. Chayama, A. Tsubota, K. Ikeda, 1995, Journal of hepatology.

Management of acute leukemia during pregnancy: from the results of a nationwide questionnaire survey and literature survey.

Y. Suzuki, S. Saitoh, S. Kawamura, 1994, The Tohoku journal of experimental medicine.

A prospective randomized administration of 5'-deoxy-5-fluorouridine as adjuvant chemotherapy for hepatocellular carcinoma treated with transcatheter arterial chemoembolization.

K. Chayama, A. Tsubota, Y. Suzuki, 1997, American journal of clinical oncology.

Histological changes in liver biopsies after one year of lamivudine treatment in patients with chronic hepatitis B infection.

K. Tanikawa, K. Chayama, A. Tsubota, 1999, Journal of hepatology.

Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2215 patients.

K. Chayama, Yoshiyuki Suzuki, A. Tsubota, 1998, Journal of hepatology.

Wild‐type precore and core promoter sequences in patients with acute self‐limited or chronic hepatitis B

A. Tsubota, Y. Suzuki, M. Kobayashi, 2004, Scandinavian journal of gastroenterology.

Susceptibility of TT virus to interferon therapy.

K. Chayama, A. Tsubota, Y. Suzuki, 1999, The Journal of general virology.

Evaluation of quantitative measurements of hepatitis C virus RNA to predict sustained response to interferon by genotype.

K. Chayama, A. Tsubota, Y. Suzuki, 2001, Journal of virological methods.

Nucleotide sequence of hepatitis C virus (type 3b) isolated from a Japanese patient with chronic hepatitis C.

K. Chayama, A. Tsubota, K. Ikeda, 1994, The Journal of general virology.

Efficacy and changes of the nonstructural 5A GENE by prolonged interferon therapy for patients with hepatitis C virus genotype 1b and a high level of serum HCV-RNA.

K. Chayama, A. Tsubota, Y. Suzuki, 1999, Internal medicine.

Pretreatment virus load and multiple amino acid substitutions in the interferon sensitivity–determining region predict the outcome of interferon treatment in patients with chronic genotype 1b hepatitis C virus infection

K. Chayama, Yoshiyuki Suzuki, A. Tsubota, 1997, Hepatology.

Chronic liver disease in the extremely elderly of 80 years or more: clinical characteristics, prognosis and patient survival analysis.

K. Chayama, Yoshiyuki Suzuki, A. Tsubota, 1999, Journal of hepatology.

Glomerulonephritis in autopsy cases with hepatitis C virus infection.

K. Chayama, A. Tsubota, K. Ikeda, 1998, Internal medicine.

A pilot study of corticosteroid priming for lymphoblastoid interferon alfa in patients with chronic hepatitis C

K. Chayama, A. Tsubota, K. Ikeda, 1996, Hepatology.

SUCCESSFUL HEMOSTASIS WITH OCTREOTIDE FOR BLEEDING FROM ULCERS DEVELOPING AFTER ENDOSCOPIC VARICEAL LIGATION ; REPORT OF TWO CASES

K. Chayama, M. Kobayashi, K. Ikeda, 1997 .